Previous studies have shown that a homozygous deletion or null genotype of the GSTM1 and GSTT1 gene that results in loss of the enzyme’s function and so increases susceptibility to head and neck cancer [45,47,48]. The gene discussed is GSTM1; the disease is head and neck cancer.